tiprankstipranks
Trending News
More News >

YiChang HEC ChangJiang Pharmaceutical Announces 2025 AGM

Story Highlights
YiChang HEC ChangJiang Pharmaceutical Announces 2025 AGM

Don’t Miss TipRanks’ Half-Year Sale

An update from YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) is now available.

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced its 2025 Annual General Meeting (AGM) scheduled for May 29, 2025, in Dongguan, Guangdong Province, China. The AGM will address several resolutions, including the approval of the 2024 annual financial reports and the re-appointment of KPMG as the company’s auditor. This meeting is significant for stakeholders as it will determine the company’s financial and operational strategies for the upcoming year.

More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. It focuses on the development, production, and sale of pharmaceutical products.

YTD Price Performance: 27.62%

Average Trading Volume: 5,076,462

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$10.74B

Find detailed analytics on 1558 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1